Logo image of QPT.CA

QUEST PHARMATECH INC (QPT.CA) Stock Fundamental Analysis

TSX-V:QPT - TSX Venture Exchange - CA74836M1068 - Common Stock - Currency: CAD

0.03  -0.01 (-14.29%)

Fundamental Rating

1

Overall QPT gets a fundamental rating of 1 out of 10. We evaluated QPT against 24 industry peers in the Biotechnology industry. Both the profitability and financial health of QPT have multiple concerns. QPT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year QPT has reported negative net income.
In the past year QPT has reported a negative cash flow from operations.
In the past 5 years QPT reported 4 times negative net income.
In the past 5 years QPT always reported negative operating cash flow.
QPT.CA Yearly Net Income VS EBIT VS OCF VS FCFQPT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

1.2 Ratios

QPT has a better Return On Assets (-1.06%) than 87.50% of its industry peers.
With an excellent Return On Equity value of -1.11%, QPT belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
Industry RankSector Rank
ROA -1.06%
ROE -1.11%
ROIC N/A
ROA(3y)-87.47%
ROA(5y)-49.52%
ROE(3y)-91.33%
ROE(5y)-51.91%
ROIC(3y)N/A
ROIC(5y)N/A
QPT.CA Yearly ROA, ROE, ROICQPT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for QPT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QPT.CA Yearly Profit, Operating, Gross MarginsQPT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50K -100K -150K

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, QPT has about the same amount of shares outstanding.
QPT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for QPT is higher compared to a year ago.
QPT.CA Yearly Shares OutstandingQPT.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
QPT.CA Yearly Total Debt VS Total AssetsQPT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 1.46, we must say that QPT is in the distress zone and has some risk of bankruptcy.
QPT's Altman-Z score of 1.46 is amongst the best of the industry. QPT outperforms 87.50% of its industry peers.
QPT has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.05, QPT is doing good in the industry, outperforming 70.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 1.46
ROIC/WACCN/A
WACCN/A
QPT.CA Yearly LT Debt VS Equity VS FCFQPT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

QPT has a Current Ratio of 0.07. This is a bad value and indicates that QPT is not financially healthy enough and could expect problems in meeting its short term obligations.
QPT has a worse Current ratio (0.07) than 79.17% of its industry peers.
A Quick Ratio of 0.07 indicates that QPT may have some problems paying its short term obligations.
QPT has a Quick ratio of 0.07. This is in the lower half of the industry: QPT underperforms 79.17% of its industry peers.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
QPT.CA Yearly Current Assets VS Current LiabilitesQPT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for QPT have decreased strongly by -101.87% in the last year.
EPS 1Y (TTM)-101.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%180.39%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
QPT.CA Yearly Revenue VS EstimatesQPT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 500K 1M 1.5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
QPT.CA Price Earnings VS Forward Price EarningsQPT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QPT.CA Per share dataQPT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04 0.06 0.08 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

QPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUEST PHARMATECH INC

TSX-V:QPT (7/11/2025, 7:00:00 PM)

0.03

-0.01 (-14.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)06-27 2025-06-27
Earnings (Next)09-22 2025-09-22
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners2.27%
Ins Owner ChangeN/A
Market Cap5.07M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.23
P/tB 0.23
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.13
TBVpS0.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.06%
ROE -1.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-87.47%
ROA(5y)-49.52%
ROE(3y)-91.33%
ROE(5y)-51.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z 1.46
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-101.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%180.39%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y23.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.86%
OCF growth 3YN/A
OCF growth 5YN/A